Commercial dose non-sterile liquid and semi-solid products, such as ointments, gels, and topical creams,  offer a number of advantages to users, such as individual dosing, ease of use and suitability for paediatric and geriatric populations.

Contract manufacturing companies support pharmaceutical companies by ensuring the stability of the formulations during production, especially liquid products.

Identifying the top commercial dose (non-sterile) companies in contract manufacturing

Pharmaceutical Technology has listed the leading commercial dose non-sterile companies in contract manufacturing based on its intel, insights, and decades of experience in the sector. The list includes companies that provide various products and services including, but not limited to:

  • Analytical testing
  • Pilot manufacturing
  • Commercial manufacturing and launch
  • Packaging, and
  • Supply chain and warehousing support

The information contained within the download document is intended for pharmaceutical manufacturers, pharmaceutical executives, product development managers, quality control executives, production engineers, and any other individual involved in pharmaceutical manufacturing.

The document contains detailed information on the suppliers and their products, alongside contact details to aid your purchasing or hiring decisions.

Safety in commercial dose non-sterile products manufacturing

Commercial dose non-sterile drug products are required to demonstrate microbiological purity criteria and are produced in controlled conditions that do not require the environment to be completely free from microorganisms. However, microbial contamination remains one of the major reasons behind product recalls of commercial dose non-sterile products.

Contract manufacturing organisations that provide manufacturing services for commercial dose non-sterile products need to ensure that their facilities are tested for microbiological contaminants and comply with the regulatory standards set for the production of these products.

Manufacturers should also routinely test their facilities for the presence of microorganisms through environmental monitoring and test their impact on the product, as well as implement effective controls to mitigate the impact. Furthermore, manufacturers can adopt risk assessment tools and certain regulations that apply to sterile manufacturing facilities to prevent microbial contamination.